Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
4.290
+0.150 (3.62%)
At close: Aug 21, 2026, 4:00 PM EDT
4.310
+0.020 (0.47%)
After-hours: Aug 21, 2026, 7:46 PM EDT

Ironwood Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Ironwood Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $6.10. The average 1-year stock price forecast is 42.19% higher than the current stock price, while the lowest is $3.70 (-13.75%) and the highest is $10 (+133.10%).

Price Target: $6.10 (+42.19%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$3.70$6.10$5.35$10
Change-13.75%+42.19%+24.71%+133.10%
* Price targets were last updated on May 6, 2026.

Analyst Ratings

The average analyst rating for Ironwood Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingNov '25Jan '26Feb '26May '26Jul '26Aug '26
Strong Buy011111
Buy011111
Hold422222
Sell000000
Strong Sell000000
Total444444

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Craig-Hallum
Craig-Hallum
Buy
Maintains
n/a
BuyMaintainsn/an/aJul 15, 2026
Wells Fargo
Wells Fargo
Hold
Maintains
$5
HoldMaintains$5+16.55%May 6, 2026
Citizens JMP
Citizens JMP
Buy
Maintains
$8$10
BuyMaintains$8$10+133.10%Feb 26, 2026

Financial Forecast

Revenue This Year
471.60M
from 296.15M
Increased by 59.24%
Revenue Next Year
493.88M
from 471.60M
Increased by 4.72%
EPS This Year
1.21
from 0.25
Increased by 384.00%
EPS Next Year
1.47
from 1.21
Increased by 21.76%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
413.75M410.60M442.74M351.41M296.15M471.60M
Revenue Growth
6.22%-0.76%7.83%-20.63%-15.73%59.24%
Operating Income
232.22M250.34M195.84M96.36M118.95M316.75M
Net Income
528.45M175.07M-1.00B880.00K24.02M203.27M
EPS
----0.251.21
EPS Growth
----525.00%384.00%
Forward PE
8.4311.2414.1413.427.843.55
Free Cash Flow
170.05M161.46M204.13M80.71M111.69M208.90M
No. Analysts
-----3
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High476.0M
Avg471.6M
Low466.6M

Revenue Growth

Revenue Growth202620272028
High
60.7%
Avg
59.2%
Low
57.6%

EPS Forecast

EPS202620272028
High1.22
Avg1.21
Low1.20

EPS Growth

EPS Growth202620272028
High
388.0%
Avg
384.0%
Low
380.0%